Allergy Therapeutics plc (LON:AGY - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 8.75 ($0.12) and last traded at GBX 8.70 ($0.12), with a volume of 195123 shares. The stock had previously closed at GBX 8.40 ($0.11).
Allergy Therapeutics Stock Performance
The firm's fifty day moving average is GBX 7.98 and its 200 day moving average is GBX 7.07. The company has a debt-to-equity ratio of 835.48, a current ratio of 1.63 and a quick ratio of 1.48. The firm has a market capitalization of £427.61 million, a price-to-earnings ratio of -8.38, a PEG ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
(
Get Free Report)
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Further Reading
Before you consider Allergy Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allergy Therapeutics wasn't on the list.
While Allergy Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
